Metformin (HCl)
Metformin (HCl) is oral biguanide antidiabetic agent, introduced in 1950s. It reduces elevated blood glucose concentration in diabetic patients, but it does not increase insulin secretion. Metformin (HCl) is used alone or in combination with insulin or chlorpropamide. Most useful in overweight subjects, where it supresses appetite. May cause nausea, vomiting and diarrhoea.
Primary Characteristics
Metformin (HCl) is also known as Metformin.
It is of Synthetic origin and belongs to Biguanide.
It belongs to Hypoglycaemics pharmacological group on the basis of mechanism of action and also classified in Antidiabetic Agent, Biguanide pharmacological group.
Molecular Weight: 165.6 · pKa: 11.5 · Solubility in Water: 1 in 2 · Solubility in Alcohol: 1 in 100 · Non-proprietary name: Metformin (HCl).

Pharmacokinetics
Absorption: Metformin (HCl) has an oral bioavailability is 55% (±5%).
Distribution: Metformin (HCl) has a volume of distribution is 63-276 litre. plasma protein binding is negligible.
Elimination: it is metabolised via Excreted unmetabolized in urine, plasma half-life is 1.5-4.5 hr, renal excretion is 90%.
Advertisement
Indications
Metformin (HCl) is primarily indicated in conditions like Diabetes mellitus, Hyperlipoproteinaemia, Insulin dependent diabetes mellitus, Insulin resistance, Non-insulin dependent diabetes mellitus, Obesity.
Contraindications
Metformin (HCl) is contraindicated in conditions like Alcohol dependence, Anaemia, Myocardial infarction, Septicaemia, Infections, Respiratory disease, Ketosis, Cardiovascular disease, Diabetic coma, Trauma, Iron deficiency, Vitamin B12 deficiency, Renal impairment, Diabetic retinopathy, Liver damage.
Dosage
Metformin (HCl)'s dosage details are as follows:
| Dose | Single Dose | Frequency | Route | Instructions |
|---|---|---|---|---|
| Adult Dosage | ||||
| 500 – 3000 mg | — | Every 12h | PO | Frequency may be increased upto 3times/day, if needed. Gradually increase upto 2-3 g/day. |
| Paediatric Dosage (20kg) | ||||
| 0 – 0 | — | — | Not recommended for this age group | |
| Neonatal Dosage (3kg) | ||||
| No data. | ||||
Drug Interactions
Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.
Side Effects
Metformin (HCl) in overdosage may give rise to further complications which include Malabsorption of vit B12, Vasculitis , Hypoglycemia, Pneumonitis , Malabsorpton of folic acid , Megaloblastic anemia.
Metformin (HCl) produces potentially life-threatening effects which include Lactic Acidosis . Careful monitoring is needed with proper medical management.
Metformin (HCl) is known to cause more or less tolerable side effects which are usually transient. These include Abdominal distension, Anorexia , Diarrhea, Flatulence, Hypersensitivity , Metallic taste, Nausea, Skin reactions, Vomiting , Weight LossX.
Warnings / Precautions
Interference in Pathology
Metformin (HCl) may interfere in the diagnosis of Serum test for Creatinine and Glucose .
Available Brands
Storage Conditions
Drug Classification
- 1.18.7.2 — Oral hypoglycemics
Manufacturers
Manufacturers of Metformin (HCl) in Pakistan: